adenosine has been researched along with Brain Ischemia in 177 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (11.86) | 18.7374 |
| 1990's | 76 (42.94) | 18.2507 |
| 2000's | 49 (27.68) | 29.6817 |
| 2010's | 21 (11.86) | 24.3611 |
| 2020's | 10 (5.65) | 2.80 |
| Authors | Studies |
|---|---|
| Gulyaeva, NV | 1 |
| Aicardi, G; Apollonio, F; Cadossi, R; Capone, F; Di Lazzaro, V; Liberti, M; Salati, S; Varani, K; Vincenzi, F | 1 |
| Cheng, P; Chu, Z; Lin, H; Liu, W; Wu, Y; Zhang, J; Zhu, J | 1 |
| Grewal, AK; Kaur, P; Khan, H; Singh, TG; Sood, S | 1 |
| Feng, J; Hao, M; Jiang, C; Li, Q; Ling, Y; Liu, F; Shang, X; Wang, B; Xiao, Z; Zhao, H; Zhao, N | 1 |
| Chen, Y; Han, W; Tian, Y; Wang, S; Zhang, E | 1 |
| Chen, J; Dong, X; Yi, Y; Zhou, L | 1 |
| Faghfoori, MH; Faghfoori, Z; Gursoy, R; Metz, GAS; Mirghani, SJ; Moghanlou, AE; Seydyousefi, M | 1 |
| Borea, PA; Casetta, I; Gessi, S; Laudisi, M; Merighi, S; Pasquini, S; Varani, K; Vincenzi, F | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Ganesana, M; Venton, BJ | 2 |
| Cui, M; Ding, H; Dong, Q; Guo, M; Wang, X; Yang, Q; Zhao, Q; Zhao, Y | 1 |
| Feng, L; Jia, HX; Li, SQ; Li, WB; Liu, XL; Sun, XC; Wu, YJ; Yuan, Q | 1 |
| Cellai, L; Corti, F; Melani, A; Pedata, F; Vannucchi, MG | 1 |
| Abbracchio, MP; Cimino, M; Enerbäck, M; Fumagalli, M; Gelosa, P; Lecca, D; Nikookhesal, E; Pignieri, A; Sironi, L; Tremoli, E; Verderio, C; Wypych, D | 1 |
| Shapkin, AG; Sufianov, AA; Sufianova, GZ | 1 |
| Lindquist, BE; Shuttleworth, CW | 1 |
| Chen, F; Cui, M; Ding, H; Dong, Q; Yang, Q; Zhao, Y | 1 |
| Burnstock, G | 1 |
| Coppi, E; Corradetti, R; Dettori, I; Fusco, I; Melani, A; Pedata, F; Pugliese, AM | 1 |
| Chen, SD; Dai, QX; Han, KY; Liu, HP; Lu, HR; Song, SW; Wang, JL | 1 |
| Dillinger, JG; Drouet, L; Henry, P; Saeed, A; Sideris, G; Silberman, SM; Sollier, CB; Spagnoli, V; Voicu, S | 1 |
| Ferguson, AL; Stone, TW | 1 |
| Cipriani, S; Galli, A; Gianfriddo, M; Giovannini, MG; Mello, T; Pedata, F; Pugliese, AM; Traini, C | 1 |
| Chen, JF; Duan, W; Gui, L; Li, C; Tian, H; Zheng, J; Zhu, J | 1 |
| Oja, SS; Saransaari, P | 3 |
| Boison, D; Lan, JQ; Lusardi, TA; Poulsen, DJ; Shen, HY; Williams-Karnesky, RL | 1 |
| Easton, JD | 1 |
| Cho, GS; Choi, IY; Choi, WJ; Hwang, S; Jeong, LS; Ju, C; Kim, WK; Lee, HW; Lee, JC | 1 |
| Bouis, D; Hayasaki, T; Hyman, MC; Petrovic-Djergovic, D; Pinsky, DJ; Ray, JJ; Visovatti, SH | 1 |
| Becker, RC; Husted, S; James, SK; Keltai, M; Khurmi, NS; Lopes, RD; Lopez-Sendon, JL; Mahaffey, KW; Maya, J; Morais, J; Nicolau, JC; Pais, P; Raev, D; Stevens, SR; Storey, RF | 1 |
| Albensi, BC; Chu, S; Parkinson, FE; Soylu, H; Sun, C; Xiong, W; Zhang, D | 1 |
| Caldwell, E; Lurie, KG; Matsuura, T; McKnite, S; Rees, J; Santacruz, K; Sarraf, M; Segal, N; Thorsgard, M; Yannopoulos, D | 1 |
| Danton, G; Dietric, WD; Prado, R; Watson, BD | 1 |
| Horiguchi, T; Inamasu, J; Kawase, T; Ogino, M; Shimizu, K; Suga, S; Yamaguchi, N | 1 |
| Auteri, A; Blardi, P; De Lalla, A; Perri, TD; Urso, R; Volpi, L | 1 |
| Higashi, H; Niiyama, S; Tanaka, E; Uematsu, K; Yokomizo, Y | 1 |
| Karasawa, A; Kusaka, H; Noji, T | 1 |
| Fredholm, BB; Goiny, M; Johansson, B; Lövdahl, C; Schulte, G; Sommerschild, H; Tokuno, S; Valen, G; Yang, J | 1 |
| Murik, SE; Shapkin, AG; Sufianov, AA; Sufianova, GZ; Taborov, MV; Usov, LA | 1 |
| Murik, SE; Shapkin, AG | 1 |
| Bardenheuer, HJ; Kiessling, M; Martin, E; Matejic, D; Plaschke, K; Schroeck, H; Sommer, C; Weigand, MA | 1 |
| Parkinson, FE; Xiong, W; Zamzow, CR | 1 |
| Cipriani, S; Gianfriddo, M; Melani, A; Pedata, F; Turchi, D; Vannucchi, MG | 1 |
| Cheng, JT; Lai, DM; Liu, IM; Tu, YK | 1 |
| Choi, JW; Choi, MS; Ko, KH; Park, GH; Ryu, MK; Yoo, BK | 1 |
| Dirnagl, U; Dreier, JP; Tille, K | 1 |
| Bright, R; Mochly-Rosen, D | 1 |
| LaManna, JC; Lust, WD; Puchowicz, MA; Xu, K | 1 |
| Boison, D; Pignataro, G; Simon, RP | 1 |
| Damian, K; Frenguelli, BG; Lynas, RE; Pearson, T | 1 |
| Boison, D; Pignataro, G; Simon, RP; Studer, FE; Wilz, A | 1 |
| Britz, GW; Meno, JR; Ngai, AC; Nguyen, TS | 1 |
| Abel, TJ; Britz, GW; Chowdhary, A; Meno, JR; Ngai, AC; Nguyen, TS; Park, IS; Winn, HR | 1 |
| Boison, D | 1 |
| Cipriani, S; Cuboni, S; Guidi, S; Martini, C; Melani, A; Pedata, F; Trincavelli, ML | 1 |
| Bortolotti, F; Colombo, G; Dalpiaz, A; Ferraro, L; Gavini, E; Giunchedi, P; Menegatti, E; Russo, P; Scatturin, A; Tanganelli, S | 1 |
| Berne, RM; Rubio, GR; Winn, HR | 1 |
| Fitzgibbons, JC; Gidday, JM; Kraujalis, MJ; Park, TS; Shah, AR | 1 |
| Carter, MF; Jacobson, KA; Lin, RC; Popik, P; Von Lubitz, DK | 1 |
| O'Regan, MH; Perkins, LM; Phillis, JW; Smith-Barbour, M | 2 |
| Park, CK; Rudolphi, KA | 1 |
| Fredholm, BB; Parkinson, FE; Rudolphi, KA | 1 |
| Gidday, JM; Gonzales, ER; Kim, YB; Park, TS; Shah, AR | 2 |
| Carter, MF; Jacobson, KA; Ji, XD; Lin, RC; Melman, N; Von Lubitz, DK | 1 |
| Kulinskiĭ, VI; Sufianova, GZ; Usov, LA | 1 |
| Kulinskiĭ, VI; Sufianov, AA; Sufianova, GZ; Usov, LA | 1 |
| Moonen, CT; van Zijl, PC | 1 |
| Fowler, JC | 2 |
| Hsu, SS; Meno, JR; Winn, HR; Zhou, JG | 1 |
| Latini, S; Pedata, F; Pepeu, G | 1 |
| Cass, CE; Parkinson, FE; Paterson, AR; Young, JD | 1 |
| Kreutzberg, GW; Schubert, P | 1 |
| Domanska-Janik, K; Pyłowa, S; Zalewska, T | 1 |
| Figge, C; Godehardt, E; Kolvenbach, R; Sandmann, W | 1 |
| Sciotti, VM; Van Wylen, DG | 1 |
| Heron, A; Lasbennes, F; Seylaz, J | 1 |
| Latini, S; Pedata, F; Pepeu, G; Pugliese, AM | 1 |
| Corsi, C; Latini, S; Pedata, F; Pepeu, G | 1 |
| Feng, YP; Hu, D; Huang, XX | 1 |
| Di Napoli, MP; Di Napoli, P | 1 |
| Beenhakker, M; Bischofberger, N; Carter, MF; Jacobson, KA; Lin, RC; Paul, IA; Von Lubitz, DK | 1 |
| de Carolis, AS; Domenici, MR; Sagratella, S | 1 |
| Mumford, PL; Pérez-Pinzón, MA; Rosenthal, M; Sick, TJ | 1 |
| Beenhakker, M; Bischofberger, N; Boyd, M; Jacobson, KA; Lin, RC; Paul, IA; Von Lubitz, DK | 1 |
| Fredholm, BB | 1 |
| Jacobson, KA; Lin, RC; Von Lubitz, DK | 1 |
| Kanthan, R; Shuaib, A | 1 |
| Sweeney, MI | 1 |
| Barth, A; Janigro, D; Meno, JR; Newell, DW; Nguyen, LB; Wender, R; Winn, HR | 1 |
| Abbracchio, MP; Brambilla, R; Cattabeni, F; Ceruti, S; Franceschi, C; Jacobson, KA; Malorni, W; von Lubitz, DK | 1 |
| Bischofberger, N; Jacobson, KA; von Lubitz, DK | 1 |
| Adami, M; Bertorelli, R; Ferri, C; Ongini, E | 1 |
| Logan, M; Sweeney, MI | 1 |
| Bari, F; Busija, DW; Louis, TM | 1 |
| Kobayashi, T; Okada, Y; Yamada, T | 2 |
| Bordoni, F; Corradetti, R; Latini, S; Pedata, F; Pepeu, G | 1 |
| Cassar, M; Jones, MG; Szatkowski, M | 1 |
| Fujishima, M; Goda, H; Ibayashi, S; Nakane, H; Ooboshi, H; Sadoshima, S | 1 |
| Von Lubitz, DK | 3 |
| Cohen, SA; Gidday, JM; Grabb, MC; Sciotti, VM; van Wylen, DG | 1 |
| Beenhakker, M; Bischofberger, N; Boyd, M; Jacobson, KA; Lin, RC; Lipartowska, R; Von Lubitz, DK | 1 |
| Bordoni, F; Corradetti, R; Latini, S; Pedata, F | 1 |
| Borea, PA; Campi, F; Gessi, S; Rodi, D; Siniscalchi, A | 1 |
| Kuang, P; Shi, J; Tao, Y | 1 |
| Bardenheuer, HJ; Eckstein, HH; Martin, E; Michel, A; Weigand, MA | 1 |
| Hansen, AJ; Judge, ME; Knutsen, LJ; Lau, J; Petersen, H; Shalmi, M; Sheardown, MJ; Thomsen, C; Weis, JU | 1 |
| Bertorelli, R; Bianchi, L; Corsi, C; Melani, A; Monopoli, A; Pantoni, L; Pedata, F; Pepeu, G | 1 |
| Fricker, J | 1 |
| LaManna, JC; Lust, WD; Xu, K; Zhou, Y | 1 |
| Abbracchio, MP; Cattabeni, F | 1 |
| Lin, RC; McClellan, J; von Lubitz, DK; Ye, W | 1 |
| Behringer, W; Hans, R; Jackson, EK; Kochanek, P; Prueckner, S; Radovsky, A; Safar, P; Stezoski, SW; Takasu, A; Tisherman, SA; Woods, RJ | 1 |
| Reshef, A; Sperling, O; Zoref-Shani, E | 2 |
| Abbracchio, MP; Picano, E | 1 |
| Nguyen, A | 1 |
| Martinez-Tica, JF; Zornow, MH | 1 |
| Bergmann, SR | 1 |
| Imura, T; Shimohama, S | 1 |
| Sperlágh, B; Vizi, ES; Zsilla, G | 1 |
| Bedell, EA; Prough, DS | 1 |
| Bardenheuer, HJ; Grant, M; Martin, E; Plaschke, K; Weigand, MA; Züchner, J | 1 |
| Bordoni, F; Corsi, C; Latini, S; Melani, A; Pedata, F | 1 |
| Lin, RC; Simpson, KL; Von Lubitz, DK | 1 |
| Bernardi, G; Calabresi, P; Centonze, D; Pisani, A; Saulle, E | 1 |
| Adén, U; Fredholm, BB; Hagberg, H; Leverin, AL | 1 |
| Kulinsky, VI; Minakina, LN; Usov, LA | 1 |
| Machiraju, VR | 1 |
| Khattab, M; Seif-el-Nasr, M | 1 |
| Rehncrona, S; Siesjö, BK; Westerberg, E | 1 |
| Berne, RM; Rubio, R; Winn, HR | 1 |
| Berne, RM; Bryner, C; Curnish, RR; Rubio, R; Winn, HR | 1 |
| Fredholm, BB; Parkinson, FE; Rudolphi, KA; Schubert, P | 2 |
| O'Regan, MH; Perkins, LM; Phillis, JW; Simpson, RE | 1 |
| Cantor, SL; Miller, LP; Yaksh, TL; Zornow, MH | 1 |
| Shibata, S; Tominaga, K; Watanabe, S | 1 |
| Dux, E; Kreutzberg, GW; Schubert, P | 1 |
| Hsu, C; Miller, LP | 1 |
| Araki, T; Hara, H; Kato, H; Kogure, K | 1 |
| Araki, T; Hara, H; Kato, H; Kogure, K; Onodera, H | 1 |
| Feng, YP; Hu, D; Li, HS; Liu, L; Zhang, JT | 1 |
| Allix, M; Boulu, RG; Callebert, J; Lekieffre, D; Plotkine, M | 1 |
| Brownstone, RM; Geiger, JD; Lesiuk, HJ; Peeling, J; Rydzy, M; Saunders, JK; Sutherland, GR | 1 |
| Gordon, EL; Hsu, SS; Meno, JR; Winn, HR; Zhou, JG | 1 |
| Donaghy, K; Scholfield, CN | 1 |
| Choi, DW | 1 |
| Marangos, PJ; von Lubitz, DK | 1 |
| Daval, JL; Deckert, J; Marangos, PJ; von Lubitz, D | 1 |
| Gidday, JM; Park, TS | 1 |
| Daval, JL; Deckert, J; Marangos, PJ; von Lubitz, DK | 1 |
| Aihara, H; Araki, H; Hayashi, M; Huang, JH; Karasawa, Y; Kawashima, K | 1 |
| Carlsson, S; Hagberg, H; Sandberg, M; Skarphedinsson, JO; Thorén, P | 1 |
| O'Regan, MH; Phillis, JW; Walter, GA | 1 |
| Palmer, GC | 1 |
| Wieloch, T | 1 |
| Andersson, P; Butcher, S; Hagberg, H; Hamberger, A; Lehmann, A; Sandberg, M | 1 |
| Blomqvist, P; Lindvall, O; Stenevi, U; Wieloch, T | 1 |
| Ashton, D; Wauquier, A | 1 |
| Dambrosia, JM; Kempski, O; Redmond, DJ; von Lubitz, DK | 1 |
| Evans, MC; Meldrum, BS; Swan, JH | 1 |
| Edlund, A; Sidén, A; Sollevi, A | 1 |
| Kogure, K; Onodera, H; Sato, G | 1 |
| Berne, RM; Park, TS; Rubio, R; Van Wylen, DG | 1 |
| Haller, C; Kuschinsky, W; Reimnitz, P | 1 |
| Hinze, HJ; Keil, M; Rudolphi, KA | 1 |
| Benuska, J; Bínovský, A; Halcák, L; Krizko, J; Pechán, I; Remis, T | 1 |
36 review(s) available for adenosine and Brain Ischemia
| Article | Year |
|---|---|
Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Electromagnetic Fields; Infarction; Ischemic Stroke; Neuroprotection; Receptors, Purinergic P1 | 2022 |
Adenosine as a Key Mediator of Neuronal Survival in Cerebral Ischemic Injury.
Topics: Adenosine; Adenosine Diphosphate; Brain Ischemia; Humans; Ischemia; Receptors, Purinergic P1 | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Humans; Nerve Regeneration; Neural Stem Cells; Neurodegenerative Diseases; Neurons; Purines; Pyrimidines; Receptors, Purinergic; Receptors, Purinergic P2X; Receptors, Purinergic P2Y; Signal Transduction; Stroke | 2016 |
Purinergic signalling in brain ischemia.
Topics: Adenosine; Adenosine Triphosphate; Animals; Brain Ischemia; Encephalitis; Humans; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P1; Receptors, Purinergic P2; Signal Transduction | 2016 |
Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).
Topics: Adenosine; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Cilostazol; Clinical Trials as Topic; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Fibrinolytic Agents; Foramen Ovale, Patent; Genotype; Humans; Ischemic Attack, Transient; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Regulation of adenosine levels during cerebral ischemia.
Topics: Adenosine; Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Humans; Neurons; Nucleoside Transport Proteins | 2013 |
Endothelium-targeted pharmacotherapeutics for the treatment of stroke.
Topics: Adenosine; Animals; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Endothelium, Vascular; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase Inhibitors; Serotonin Antagonists; Stroke; Vasodilator Agents | 2002 |
Interactions of taurine and adenosine in the mouse hippocampus in normoxia and ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Hippocampus; Mice; Oxygen; Taurine | 2003 |
Adenosine uptake inhibitors.
Topics: Adenosine; Animals; Brain Ischemia; Forecasting; Humans; Models, Biological; Molecular Structure; Myocardial Reperfusion Injury; Nucleoside Transport Proteins | 2004 |
The role of protein kinase C in cerebral ischemic and reperfusion injury.
Topics: Adenosine; Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Humans; Ischemic Preconditioning; Isoenzymes; Neurons; Protein Kinase C; Reperfusion Injury; Up-Regulation | 2005 |
Adenosine as a neuromodulator in neurological diseases.
Topics: Adenosine; Adenosine Kinase; Alzheimer Disease; Animals; Brain Diseases; Brain Ischemia; Epilepsy; Humans; Huntington Disease; Pain; Parkinson Disease; Schizophrenia; Synaptic Transmission | 2008 |
Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia.
Topics: Adenosine; Animals; Biological Transport; Brain Ischemia; Cells, Cultured; Cerebrovascular Circulation; Depression, Chemical; Excitatory Amino Acid Antagonists; Gerbillinae; Humans; Receptors, Purinergic P1; Xanthines | 1994 |
Cerebral protection by adenosine.
Topics: Adenosine; Animals; Brain Damage, Chronic; Brain Ischemia; Calcium; Culture Techniques; Dizocilpine Maleate; Epilepsy, Post-Traumatic; Gerbillinae; Hippocampus; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1993 |
Adenosine and neuroprotection.
Topics: Adenosine; Animals; Brain Ischemia; Humans; Hypoxia, Brain; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 1997 |
Amplification of inhibitory mechanisms in cerebral ischemia: an alternative approach to neuronal protection.
Topics: Adenosine; Animals; Brain Ischemia; Calcium Channels; gamma-Aminobutyric Acid; Humans; Hypothermia, Induced; Neurons; Norepinephrine; Receptors, Metabotropic Glutamate; Serotonin; Sodium Channel Blockers; Synapses; Taurine | 1997 |
Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity.
Topics: Adenosine; Animals; Brain Ischemia; Neurons; Neuroprotective Agents | 1997 |
Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
Topics: Adenosine; Animals; Apoptosis; Astrocytes; Brain; Brain Ischemia; Humans; Nervous System Diseases; Neuroprotective Agents; Receptor, Adenosine A3; Receptors, Purinergic P1; Synaptic Transmission | 1997 |
Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Cell Survival; Humans; Ischemic Attack, Transient; Neurons; Neuroprotective Agents; Purinergic P1 Receptor Agonists | 1997 |
Adenosine A2A receptors and neuroprotection.
Topics: Adenosine; Animals; Brain; Brain Diseases; Brain Ischemia; Dopamine; Humans; Neuroprotective Agents; Parkinson Disease; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Seizures | 1997 |
Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
Topics: Adenosine; Animals; Brain Ischemia; Cardiovascular Agents; Humans; Purinergic P1 Receptor Agonists | 1999 |
Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
Topics: Adenosine; Animals; Brain Ischemia; Humans; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1 | 1999 |
Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?
Topics: Adenosine; Animals; Brain Ischemia; Mice; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1 | 1999 |
Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector.
Topics: Adenosine; Animals; Brain Ischemia; Cardiotonic Agents; Humans; Myocardial Ischemia; Neuroprotective Agents | 2000 |
Prothrombin G20210A polymorphism and thrombophilia.
Topics: Adenosine; Africa; Asia; Asian People; Black People; Brain Ischemia; Brazil; Coronary Disease; Europe; Factor V; Genetic Testing; Guanosine; Homozygote; Humans; Point Mutation; Polymorphism, Genetic; Prevalence; Prothrombin; Risk Factors; Thrombophilia; Thrombosis; United States; White People | 2000 |
Cerebral ischemia in humans after traumatic brain injury.
Topics: Adenosine; Brain Chemistry; Brain Injuries; Brain Ischemia; Extracellular Space; Humans; Jugular Veins; Monitoring, Physiologic; Xanthine | 2001 |
Adenosine in the treatment of stroke: yes, maybe, or absolutely not?
Topics: Adenosine; Brain Ischemia; Humans; Phosphatidylinositols; Receptors, Purinergic P1; Stroke | 2001 |
Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Extracellular Space; Humans; Infarction, Middle Cerebral Artery; Receptor, Adenosine A2A; Receptors, Purinergic P1 | 2001 |
Neuroprotective role of adenosine in cerebral ischaemia.
Topics: Adenosine; Animals; Brain Ischemia; Humans; Receptors, Purinergic | 1992 |
Adenosine and brain ischemia.
Topics: Adenosine; Animals; Brain Chemistry; Brain Ischemia; Humans; Receptors, Purinergic | 1992 |
Therapeutic potential for adenosine receptor activation in ischemic brain injury.
Topics: Adenosine; Animals; Brain; Brain Injuries; Brain Ischemia; Humans; Models, Neurological; Receptors, Purinergic | 1992 |
Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists.
Topics: Adenosine; Animals; Brain Ischemia; Calcium; Glutamates; Hydrogen-Ion Concentration; Hypoxia; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Zinc | 1990 |
Adenosine: its relevance to the treatment of brain ischemia and trauma.
Topics: Adenosine; Animals; Brain Injuries; Brain Ischemia | 1990 |
Cyclic nucleotides in stroke and related cerebrovascular disorders.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Adenylyl Cyclases; Animals; Brain; Brain Ischemia; Brain Neoplasms; Capillaries; Cerebrovascular Disorders; Cyclic AMP; Cyclic GMP; gamma-Aminobutyric Acid; Guanylate Cyclase; Humans; Hypoxia, Brain; In Vitro Techniques; Lactates; Lactic Acid; Norepinephrine; Phospholipids; Protein Kinases; Synaptic Membranes; Tissue Distribution | 1985 |
Neurochemical correlates to selective neuronal vulnerability.
Topics: Adenosine; Afferent Pathways; Animals; Aspartic Acid; Brain Diseases; Brain Ischemia; Calcium; Chlorides; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hypoglycemia; Models, Biological; Neural Inhibition; Neurochemistry; Neurons; Neurotransmitter Agents; Norepinephrine; Parasympathomimetics; Quinolinic Acid; Quinolinic Acids; Rats | 1985 |
The pharmacological basis for the treatment of brain ischemia and hypoxia.
Topics: Adenosine; Amino Acids; Animals; Brain Ischemia; Calcium; Cerebrovascular Circulation; Fatty Acids, Nonesterified; Hypoxia, Brain; Oxygen; Vasodilator Agents | 1988 |
2 trial(s) available for adenosine and Brain Ischemia
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Risk Factors; Stroke; Ticagrelor; Ticlopidine | 2012 |
140 other study(ies) available for adenosine and Brain Ischemia
| Article | Year |
|---|---|
Does the inability of CA1 area to respond to ischemia with early rapid adenosine release contribute to hippocampal vulnerability?: An Editorial Highlight for "Spontaneous, transient adenosine release is not enhanced in the CA1 region of hippocampus during
Topics: Adenosine; Brain Ischemia; Hippocampus; Humans; Ischemia; Microelectrodes | 2021 |
A3 adenosine receptor agonist IB-MECA reverses chronic cerebral ischemia-induced inhibitory avoidance memory deficit.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Brain Ischemia; Memory Disorders; Mice | 2022 |
Serum adenosine deaminase activity and acute cerebral infarction: a retrospective case-control study based on 7913 participants.
Topics: Adenosine; Adenosine Deaminase; Brain Ischemia; Case-Control Studies; Cerebral Infarction; Humans; Retrospective Studies; Stroke | 2022 |
Adenosine receptor A1 enhanced mitochondrial biogenesis and exerted neuroprotection after cerebral ischemia through PGC-1α.
Topics: Adenosine; Animals; Brain Ischemia; Ischemic Stroke; Mice; Neuroprotection; Organelle Biogenesis; Receptors, Purinergic P1; Stroke | 2023 |
The role of endurance exercise and adenosine on monocyte chemotactic protein-1 (MCP-1) gene expression in male rat brain ischemia-reperfusion.
Topics: Adenosine; Animals; Brain Ischemia; Chemokine CCL2; Gene Expression; Ischemic Stroke; Male; Physical Conditioning, Animal; Rats; Rats, Wistar; Reperfusion | 2023 |
Exogenous adenosine facilitates neuroprotection and functional recovery following cerebral ischemia in rats.
Topics: Adenosine; Animals; Brain; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Disease Models, Animal; Hippocampus; Male; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Rats, Wistar; Recovery of Function; Reperfusion Injury | 2019 |
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes.
Topics: 5'-Nucleotidase; Adenosine; Aged; Aged, 80 and over; Antigens, CD; Apyrase; Brain Ischemia; Female; GPI-Linked Proteins; Humans; Ischemic Stroke; Lymphocytes; Male; Membrane Proteins; Phosphoproteins; Receptors, Purinergic P1; Stroke | 2020 |
Spontaneous, transient adenosine release is not enhanced in the CA1 region of hippocampus during severe ischemia models.
Topics: Adenosine; Animals; Brain Ischemia; CA1 Region, Hippocampal; Cerebrovascular Circulation; Male; Patient Acuity; Rats; Rats, Sprague-Dawley | 2021 |
Ischemic preconditioning with a ketogenic diet improves brain ischemic tolerance through increased extracellular adenosine levels and hypoxia-inducible factors.
Topics: Adenosine; Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Brain Ischemia; Cell Line, Tumor; Cerebrovascular Circulation; Diet, Ketogenic; Disease Models, Animal; Extracellular Space; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemic Preconditioning; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Neuroprotection; Phosphorylation; Proto-Oncogene Proteins c-akt; Random Allocation; Receptor, Adenosine A1; Vascular Endothelial Growth Factor A | 2017 |
Early changes in transient adenosine during cerebral ischemia and reperfusion injury.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Male; Rats, Sprague-Dawley; Reperfusion Injury | 2018 |
The role of adenosine in up-regulation of p38 MAPK and ERK during limb ischemic preconditioning-induced brain ischemic tolerance.
Topics: Adenosine; Animals; Brain Ischemia; CA1 Region, Hippocampal; Extremities; Ischemic Preconditioning; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A1; Transcriptional Activation; Up-Regulation; Xanthines | 2019 |
Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Pressure; Body Weight; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Gliosis; Heart Rate; Male; Motor Activity; Neuroprotective Agents; Phenethylamines; Rats; Rats, Wistar; Weight Loss | 2014 |
Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor.
Topics: Adenosine; Animals; Brain Ischemia; Chemokine CCL2; Ectodysplasins; Fibrinolytic Agents; Interleukin-1; Mice; Mice, Transgenic; Microglia; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Stroke; Ticagrelor; Time Factors | 2014 |
Effect of cyclopentyladenosine on lipid peroxidation during focal cerebral ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Lipid Peroxidation; Male; Neuroprotective Agents; Rats | 2014 |
Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo.
Topics: Adenosine; Animals; Biomarkers; Brain; Brain Ischemia; Cortical Spreading Depression; Mice; Stroke | 2014 |
Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Astrocytes; Blood-Brain Barrier; Brain Ischemia; Cells, Cultured; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Dynamins; Extracellular Space; Hydrolysis; Male; Mice, Inbred C57BL; Neuroprotective Agents; Quinazolinones; Receptor, Adenosine A1; Recovery of Function; Signal Transduction; Up-Regulation | 2016 |
[Adenosine Al Receptor Mediated Neuroprotection of Shenmai Injection on Rat Cerebral Ischemia/Reperfusion Injury: an Experimental Study].
Topics: Adenosine; Animals; Brain Ischemia; Drug Combinations; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; Mice; Neuroprotection; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Reperfusion Injury; Xanthines | 2015 |
High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
Topics: Acute Disease; Adenosine; Aspirin; Blood Platelets; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Survival Analysis; Ticagrelor; Ticlopidine | 2016 |
Adenosine preconditions against ouabain but not against glutamate on CA1-evoked potentials in rat hippocampal slices.
Topics: Adenosine; Animals; Brain Ischemia; Enzyme Inhibitors; Evoked Potentials; Glutamic Acid; Hippocampus; Ischemic Preconditioning; Male; Nitric Oxide Synthase Type I; Organ Culture Techniques; Ouabain; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sodium-Potassium-Exchanging ATPase | 2008 |
The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Astrocytes; Blotting, Western; Brain Ischemia; Cell Hypoxia; Cell Survival; Coloring Agents; Excitatory Postsynaptic Potentials; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Immunohistochemistry; In Vitro Techniques; Male; Neurons; Neuroprotective Agents; Oxygen; Phenethylamines; Propidium; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Staining and Labeling; Time Factors; Triazines; Triazoles | 2009 |
Adenosine A 2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice.
Topics: Adenosine; Animals; Brain Chemistry; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Down-Regulation; Extracellular Fluid; Gene Expression Regulation; Genetic Predisposition to Disease; Glutamic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Receptor, Adenosine A2A; Up-Regulation | 2009 |
Adenosine receptor agonists affect taurine release from mouse brain stem slices in ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Brain Stem; Female; Male; Mice; Phenethylamines; Purinergic P1 Receptor Agonists; Taurine; Xanthines | 2010 |
Adenosine kinase determines the degree of brain injury after ischemic stroke in mice.
Topics: Adenosine; Adenosine Kinase; Animals; Brain; Brain Ischemia; Cerebral Cortex; Down-Regulation; Gene Deletion; Gene Expression; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Up-Regulation | 2011 |
A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Brain Infarction; Brain Injuries; Brain Ischemia; Cell Movement; Chemokine CCL2; Glucose; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Microglia; Monocytes; N-Methylaspartate; Protein Transport; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; rho GTP-Binding Proteins; Thionucleosides; Tumor Necrosis Factor-alpha | 2011 |
Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain.
Topics: 5'-Nucleotidase; Adenosine; Animals; Bone Marrow Transplantation; Brain Edema; Brain Ischemia; Cell Movement; Extracellular Fluid; Infarction, Middle Cerebral Artery; Inflammation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Tissue Distribution | 2012 |
Ischemic post-conditioning and vasodilator therapy during standard cardiopulmonary resuscitation to reduce cardiac and brain injury after prolonged untreated ventricular fibrillation.
Topics: Adenosine; Animals; Brain Ischemia; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Epinephrine; Heart Arrest; Ischemic Postconditioning; Models, Cardiovascular; Nitroprusside; Stroke Volume; Swine; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Fibrillation; Ventricular Function, Left | 2013 |
Neuroprotection role of adenosine under hypothermia in the rat global ischemia involves inhibition of not dopamine release but delayed postischemic hypoperfusion.
Topics: Adenosine; Animals; Brain Ischemia; Corpus Striatum; Dopamine; Hypothermia; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion | 2002 |
Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia.
Topics: Adenosine; Adult; Aged; Area Under Curve; Brain Ischemia; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Nimodipine | 2002 |
The presynaptic modulation of glutamate release and the membrane dysfunction induced by in vitro ischemia in rat hippocampal CA1 neurons.
Topics: Adenosine; Animals; Brain Ischemia; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA-B Receptor Antagonists; Glutamic Acid; Hippocampus; Male; Membrane Potentials; Membranes; Microelectrodes; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Receptors, Presynaptic | 2002 |
Adenosine A receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia.
Topics: Adaptation, Physiological; Adenosine; Animals; Brain Ischemia; Gene Deletion; Heart; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Knockout; Microdialysis; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Ischemia; Myocardial Reperfusion; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptor, Adenosine A1; Ventricular Function, Left | 2004 |
Changes in the steady-state potential in rats with focal cerebral ischemia receiving cyclopentyladenosine.
Topics: Action Potentials; Adenosine; Animals; Brain Ischemia; Disease Models, Animal; Female; Infarction, Middle Cerebral Artery; Male; Microelectrodes; Neuroprotective Agents; Parietal Lobe; Rats; Time Factors | 2003 |
Simultaneous recording of eeg and direct current (DC) potential makes it possible to assess functional and metabolic state of nervous tissue.
Topics: Adenosine; Animals; Brain Ischemia; Cerebral Cortex; Contingent Negative Variation; Electricity; Electrodes; Electroencephalography; Functional Laterality; Nerve Tissue; Rats; Statistics, Nonparametric; Time Factors | 2004 |
A mouse model of cerebral oligemia: relation to brain histopathology, cerebral blood flow, and energy state.
Topics: Adenosine; Adenosine Triphosphate; Animals; Biomarkers; Brain Ischemia; Carotid Stenosis; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Down-Regulation; Energy Metabolism; Female; Mice; Mice, Inbred DBA; Nerve Degeneration; Neurons; Oxidative Phosphorylation; Phosphocreatine; Up-Regulation | 2005 |
Astrocytes and neurons: different roles in regulating adenosine levels.
Topics: Adenosine; Affinity Labels; Animals; Astrocytes; Brain Ischemia; Cells, Cultured; Deoxyglucose; Dipyridamole; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Hypoxia; Inosine; Models, Biological; Neurons; Oligomycins; Phosphodiesterase Inhibitors; Prosencephalon; Purines; Rats; Thioinosine; Tritium | 2005 |
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Enzyme Inhibitors; Extracellular Fluid; Infarction, Middle Cerebral Artery; Male; Microdialysis; Movement Disorders; Rats; Rats, Wistar; Receptors, Purinergic P2; Up-Regulation | 2005 |
Increase of adenosine A1 receptor gene expression in cerebral ischemia of Wistar rats.
Topics: Adenosine; Animals; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Cytoprotection; Disease Models, Animal; Gene Expression Regulation; Male; Nerve Degeneration; Rats; Rats, Wistar; Receptor, Adenosine A1; Reperfusion Injury; RNA, Messenger; Up-Regulation | 2005 |
GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Brain Ischemia; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Kinetics; Mice; Neurons; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Stimulation, Chemical | 2005 |
Adenosine and purine nucleosides prevent the disruption of mitochondrial transmembrane potential by peroxynitrite in rat primary astrocytes.
Topics: Adenosine; Animals; Astrocytes; Brain Ischemia; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Glucose; Intracellular Membranes; Membrane Potentials; Mitochondria; Molsidomine; Peroxynitrous Acid; Purine Nucleosides; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2005 |
Partial antagonistic effect of adenosine on inverse coupling between spreading neuronal activation and cerebral blood flow in rats.
Topics: Adenosine; Administration, Topical; Animals; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Cortical Spreading Depression; Evoked Potentials; Hyperemia; Male; Rats; Rats, Wistar | 2004 |
Adenosine treatment delays postischemic hippocampal CA1 loss after cardiac arrest and resuscitation in rats.
Topics: Adenosine; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Body Temperature; Brain Edema; Brain Ischemia; Cell Count; Cell Death; Disease Models, Animal; Heart Arrest; Hippocampus; Male; Neurons; Physical Examination; Rats; Rats, Wistar; Recovery of Function; Regional Blood Flow; Reperfusion; Resuscitation; Time Factors; Water | 2006 |
Transgenic overexpression of adenosine kinase aggravates cell death in ischemia.
Topics: Adenosine; Adenosine Kinase; Animals; Brain Ischemia; Cell Death; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Functional Laterality; Hippocampus; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Promoter Regions, Genetic; Pyramidal Cells; Receptor, Adenosine A1; Tubercidin; Ubiquitin | 2007 |
Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Brain Ischemia; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Extracellular Fluid; Female; Hippocampus; Male; Neural Inhibition; Neurons; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2006 |
Neuroprotection in ischemic mouse brain induced by stem cell-derived brain implants.
Topics: Adenosine; Adenosine Kinase; Alleles; Animals; Brain Ischemia; Cerebral Infarction; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nervous System Diseases; Neurons; Stem Cell Transplantation | 2007 |
Postischemic augmentation of conducted dilation in cerebral arterioles.
Topics: Adenosine; Adenosine Triphosphate; Animals; Arterioles; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Microcirculation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tetrazolium Salts; Vasoconstriction; Vasodilation; Vasomotor System | 2007 |
Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage.
Topics: Adenosine; Afferent Pathways; Animals; Arterioles; Brain Ischemia; Carbon Dioxide; Cerebral Arteries; Cerebral Cortex; Electric Stimulation; Evoked Potentials, Somatosensory; Male; Nitroprusside; Rats; Rats, Sprague-Dawley; Sensation; Subarachnoid Hemorrhage; Subarachnoid Space; Time Factors; Vasoconstriction; Vasodilator Agents; Vasospasm, Intracranial | 2007 |
Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Astrocytes; Behavior, Animal; Brain; Brain Ischemia; Disease Models, Animal; Gene Expression Regulation; Guanosine 5'-O-(3-Thiotriphosphate); Male; Motor Activity; Neurologic Examination; Phenethylamines; Rats; Rats, Wistar; Receptors, Adenosine A2 | 2008 |
Brain uptake of an anti-ischemic agent by nasal administration of microparticles.
Topics: Adenosine; Administration, Intranasal; Animals; Brain; Brain Ischemia; Chromatography, High Pressure Liquid; Drug Carriers; Male; Microscopy, Electron, Scanning; Microspheres; Particle Size; Rats; Rats, Wistar; Sensitivity and Specificity; Sheep | 2008 |
The role of adenosine in the regulation of cerebral blood flow.
Topics: Adenosine; Animals; Brain Ischemia; Cats; Cerebrovascular Circulation; Dogs; Hypotension; Hypoxia; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium; Rabbits; Seizures | 1981 |
Reduction in cerebral ischemic injury in the newborn rat by potentiation of endogenous adenosine.
Topics: Adenosine; Animals; Animals, Newborn; Body Temperature; Brain; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Neuroprotective Agents; Organ Size; Pentostatin; Rats; Rats, Sprague-Dawley; Xanthines | 1995 |
Adenosine A3 receptor stimulation and cerebral ischemia.
Topics: Adenosine; Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Drug Administration Schedule; Female; Gerbillinae; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Xanthines | 1994 |
Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Cerebral Arteries; Constriction; Excitatory Amino Acids; gamma-Aminobutyric Acid; Inosine; Male; Purines; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
Antiischemic effects of propentofylline (HWA 285) against focal cerebral infarction in rats.
Topics: Adenosine; Animals; Behavior, Animal; Brain Ischemia; Cerebral Infarction; Male; Nervous System; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Xanthines | 1994 |
Indomethacin modulates ischemia-evoked release of glutamate and adenosine from the rat cerebral cortex.
Topics: Adenosine; Animals; Aspartic Acid; Blood Pressure; Brain Ischemia; Cell Death; Cerebral Cortex; Electroencephalography; gamma-Aminobutyric Acid; Glutamic Acid; Indomethacin; Rats; Rats, Sprague-Dawley; Reperfusion | 1994 |
Effect of hypoglycemia on postischemic cortical blood flow, hypercapnic reactivity, and interstitial adenosine concentration.
Topics: Adenosine; Animals; Animals, Newborn; Blood Pressure; Brain Ischemia; Carbon Dioxide; Cerebral Cortex; Cerebrovascular Circulation; Extracellular Space; Hypercapnia; Hypoglycemia; Hypoxanthine; Hypoxanthines; Inosine; Swine; Xanthine; Xanthines | 1994 |
Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.
Topics: Adenosine; Animals; Body Temperature; Brain Ischemia; Down-Regulation; Female; Gerbillinae; Hippocampus; Prosencephalon; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Up-Regulation; Xanthines | 1994 |
[Protective effect of adenosine in total brain ischemia].
Topics: Adenosine; Animals; Brain Ischemia; Male; Mice; Nucleosides; Nucleotides; Receptors, Purinergic P1 | 1993 |
[The protective effect of intracerebroventricular administration of A-agonists in complete cerebral ischemia].
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Ischemia; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Male; Mice; Receptors, Purinergic P1; Vasodilator Agents | 1994 |
In situ changes in purine nucleotide and N-acetyl concentrations upon inducing global ischemia in cat brain.
Topics: Acetylation; Adenosine; Animals; Aspartic Acid; Brain Ischemia; Cats; Choline; Creatine; Female; gamma-Aminobutyric Acid; Glucose; Glutamates; Glutamic Acid; Glycine; Magnetic Resonance Spectroscopy; Male; Purine Nucleotides; Taurine | 1993 |
Purine release and inhibition of synaptic transmission during hypoxia and hypoglycemia in rat hippocampal slices.
Topics: Adenine; Adenosine; Animals; Brain Ischemia; Electric Stimulation; Electrophysiology; Evoked Potentials; Hippocampus; Hypoglycemia; Hypoxia, Brain; In Vitro Techniques; Male; Purines; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Synapses; Synaptic Transmission | 1993 |
Effects of theophylline and cyclohexyladenosine on brain injury following normo- and hyperglycemic ischemia: a histopathologic study in the rat.
Topics: Adenosine; Animals; Blood Pressure; Brain; Brain Ischemia; Hyperglycemia; Male; Osmolar Concentration; Rats; Rats, Wistar; Reference Values; Theophylline | 1994 |
Effect of idebenone on adenosine outflow and adenine nucleotide level in hippocampal slices under ischemia-like conditions.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzoquinones; Brain Ischemia; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Inosine; Male; Rats; Rats, Wistar; Ubiquinone | 1993 |
Inhibitory effects of propentofylline on [3H]adenosine influx. A study of three nucleoside transport systems.
Topics: Adenosine; Animals; Biological Transport; Brain Ischemia; Cell Line; Mice; Rats; Thioinosine; Tritium; Tumor Cells, Cultured; Xanthines | 1993 |
Coupling of adenosine receptors to adenylate cyclase in postischemic rat brain.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Binding, Competitive; Brain Ischemia; Calcium; Colforsin; Cyclic AMP; Down-Regulation; Edetic Acid; Egtazic Acid; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Heart Arrest; Male; Models, Biological; Rats; Rats, Wistar; Receptors, Purinergic; Signal Transduction | 1993 |
Adenosine agonists and global cerebral ischaemia.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Male; Rats; Rats, Wistar; Xanthines | 1993 |
Attenuation of ischemia-induced extracellular adenosine accumulation by homocysteine.
Topics: Adenosine; Analysis of Variance; Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Extracellular Space; Homocysteine; Hypoxanthine; Hypoxanthines; Inosine; Male; Rats; Rats, Wistar; S-Adenosylhomocysteine | 1993 |
Adenosine modulation of amino acid release in rat hippocampus during ischemia and veratridine depolarization.
Topics: Adenosine; Amino Acids; Animals; Brain Ischemia; Dialysis; Hippocampus; Infusions, Parenteral; Male; Membrane Potentials; Micromanipulation; Phenylisopropyladenosine; Rats; Rats, Wistar; Theophylline; Veratridine | 1993 |
Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions.
Topics: 5'-Nucleotidase; Adenosine; Amino Acids; Animals; Brain Ischemia; Calcium; Electric Stimulation; Electrophysiology; Hippocampus; In Vitro Techniques; Inosine; Male; Rats; Rats, Wistar; Tetrodotoxin | 1993 |
The source of brain adenosine outflow during ischemia and electrical stimulation.
Topics: Adenine Nucleotides; Adenosine; Adenosylhomocysteinase; Animals; Brain; Brain Ischemia; Chromatography, High Pressure Liquid; Electric Stimulation; Hippocampus; Hydrolases; In Vitro Techniques; Male; Rats; Rats, Wistar; S-Adenosylhomocysteine | 1996 |
[Effect of dl-3-n-butylphthalide (NBP) on purine metabolites in striatum extracellular fluid in four-vessel occlusion rats].
Topics: Adenosine; Animals; Benzofurans; Brain Ischemia; Corpus Striatum; Extracellular Space; Inosine; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion; Stereoisomerism; Xanthines | 1996 |
Cytosolic phospholipase A2 induction after global ischemia: don't forget the role of adenosine.
Topics: Adenosine; Animals; Brain Ischemia; Cytosol; Enzyme Induction; Humans; Models, Neurological; Phospholipases A; Phospholipases A2 | 1996 |
Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Brain Ischemia; Female; Gerbillinae; Maze Learning; Memory; Motor Activity; Purinergic P1 Receptor Agonists | 1996 |
Block by N6-L-phenylisopropyl-adenosine of the electrophysiological and morphological correlates of hippocampal ischaemic injury in the gerbil.
Topics: Adenosine; Animals; Brain Ischemia; Electrophysiology; Gerbillinae; Hippocampus; Male; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Pyramidal Cells | 1996 |
Adenosine transport inhibition ameliorates postischemic hypoperfusion in pigs.
Topics: Adenosine; Animals; Biological Transport; Brain; Brain Ischemia; Cerebrovascular Circulation; Purines; Reperfusion; Swine; Thioinosine | 1996 |
Anoxic preconditioning in hippocampal slices: role of adenosine.
Topics: Adenosine; Animals; Brain Ischemia; Evoked Potentials; Hippocampus; Hypoxia; In Vitro Techniques; Male; Rats; Rats, Wistar | 1996 |
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils.
Topics: Adenosine; Animals; Brain Ischemia; Cell Survival; Female; Gerbillinae; Hippocampus; Immunohistochemistry; Prognosis | 1996 |
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
Topics: Adenosine; Animals; Brain Ischemia; Caffeine; Cell Survival; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Female; Gerbillinae; Hippocampus; Laser-Doppler Flowmetry; Neurons; Phenethylamines; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Treatment Outcome | 1995 |
Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Animals, Newborn; Brain Ischemia; Cell Survival; Enzyme Inhibitors; Hippocampus; Neurons; Neurotoxins; Nitric Oxide; Organ Culture Techniques; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Theobromine; Theophylline; Xanthines | 1997 |
Adenosine A1 receptor activation preferentially protects cultured cerebellar neurons versus astrocytes against hypoxia-induced death.
Topics: Adenosine; Animals; Astrocytes; Brain Ischemia; Cell Death; Cells, Cultured; Cerebellum; Hypoglycemia; Hypoxia, Brain; In Vitro Techniques; L-Lactate Dehydrogenase; Neurons; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley | 1997 |
Effects of ischemia on cerebral arteriolar dilation to arterial hypoxia in piglets.
Topics: Adenosine; Adenosine Triphosphate; Administration, Topical; Analysis of Variance; Animals; Arterioles; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Female; Glyburide; Hypercapnia; Hypoglycemic Agents; Hypoxia; Injections, Intravenous; Intracranial Hypertension; Male; Potassium Channel Blockers; Potassium Channels; Purinergic P1 Receptor Antagonists; Reperfusion; Swine; Theophylline; Vasodilation; Vasodilator Agents | 1998 |
The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia-in vivo study.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Animals; Brain; Brain Chemistry; Brain Ischemia; Chromatography, High Pressure Liquid; Dyneins; Enzyme Inhibitors; Guinea Pigs; Hypoxanthine; Inosine; Male; Microwaves; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; Tissue Fixation | 1998 |
The effects of simulated ischemia on the levels of adenosine and its metabolites in slices of cerebellum, superior colliculus and hippocampus in the guinea pig-in vitro study.
Topics: Adenosine; Animals; Brain Chemistry; Brain Ischemia; Cerebellum; Guinea Pigs; Hippocampus; Hypoxanthine; In Vitro Techniques; Inosine; Male; Microwaves; Superior Colliculi | 1998 |
Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions.
Topics: Adenosine; Animals; Brain Ischemia; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Rats; Rats, Wistar; Synaptic Transmission; Time Factors | 1998 |
Reduced adenosine uptake accelerates ischaemic block of population spikes in hippocampal slices from streptozotocin-treated diabetic rats.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Brain Ischemia; Diabetes Mellitus, Experimental; Hippocampus; Hypoglycemia; Hypoxia, Brain; Male; Rats; Rats, Wistar; Synaptic Transmission; Thioinosine; Xanthines | 1998 |
Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine A1 receptor agonist.
Topics: Adenosine; Amino Acids; Animals; Aspartic Acid; Brain; Brain Ischemia; gamma-Aminobutyric Acid; Glutamic Acid; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred SHR; Regional Blood Flow; Taurine | 1998 |
Neurochemical and morphological responses to acutely and chronically implanted brain microdialysis probes.
Topics: Adenosine; Animals; Brain Ischemia; Chromatography, High Pressure Liquid; Diffusion; Hemodynamics; Immunohistochemistry; Implants, Experimental; Male; Microdialysis; Monitoring, Physiologic; Neurotransmitter Agents; Purine Nucleotides; Rats; Rats, Wistar | 1998 |
Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
Topics: Adenosine; Analysis of Variance; Animals; Brain Ischemia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gerbillinae; Hippocampus; Injections, Intraperitoneal; Purinergic P1 Receptor Agonists | 1999 |
Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.
Topics: Adenosine; Animals; Brain Ischemia; Extracellular Space; Hippocampus; In Vitro Techniques; Kinetics; Male; Oxygen; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synaptic Transmission; Theophylline; Xanthines | 1999 |
Early changes in adenosine A1 receptors in cerebral cortex slices submitted to in vitro ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Cerebral Cortex; Male; Purines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reperfusion | 1999 |
Effect of radix Salviae miltiorrhizae on extracellular adenosine and evaluation of its protective efficacy in ischemic reperfusion rat--microdialysis, HPLC and histopathologic studies.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Extracellular Space; Hippocampus; Male; Microdialysis; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Salvia miltiorrhiza | 1997 |
Adenosine: a sensitive indicator of cerebral ischemia during carotid endarterectomy.
Topics: Adenosine; Adenosine Triphosphate; Aged; Brain; Brain Ischemia; Cerebrovascular Circulation; Endarterectomy, Carotid; Evoked Potentials, Somatosensory; Female; Humans; Lactic Acid; Male; Middle Aged | 1999 |
N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
Topics: Adenosine; Animals; Blood Pressure; Brain; Brain Ischemia; Cardiovascular System; Cell Line; Gerbillinae; Guinea Pigs; Hypotension; Mice; Mice, Inbred Strains; Neuroprotective Agents; Protein Binding; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred Strains | 1999 |
Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage.
Topics: Adenosine; Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acids; gamma-Aminobutyric Acid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Microdialysis; Middle Cerebral Artery; Neurologic Examination; Neurotransmitter Agents; Psychomotor Performance; Rats; Rats, Wistar; Suture Techniques; Taurine | 1999 |
Unravelling adenosine's effects on stroke.
Topics: Adenosine; Animals; Brain Ischemia; Gene Deletion; Glutamic Acid; Humans; Mice; Mice, Knockout; Neurodegenerative Diseases; Neuroprotective Agents; Phenotype; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Stroke | 2000 |
Adenosine improves cerebral recovery in rat after cardiac arrest and resuscitation.
Topics: Adenosine; Animals; Brain; Brain Edema; Brain Ischemia; Cardiopulmonary Resuscitation; Cell Death; Heart Arrest; Male; Neurons; Rats; Rats, Wistar | 1999 |
Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Topics: Adenosine; Animals; Astrocytes; Brain Infarction; Brain Ischemia; Cell Death; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles | 1999 |
Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs - an exploratory study.
Topics: Adenosine; Animals; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Heart Arrest; Hemodynamics; Hypothermia, Induced; Infusions, Intra-Arterial; Male; Reference Values; Shock, Hemorrhagic; Survival Rate; Vasodilator Agents | 2000 |
Opening of K(ATP) channels is mandatory for acquisition of ischemic tolerance by adenosine.
Topics: Adenosine; Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Cell Death; Cells, Cultured; Glyburide; Ischemic Preconditioning; Neurons; Neuroprotective Agents; Potassium Channel Blockers; Potassium Channels; Rats; Reference Values; Reperfusion Injury | 2000 |
Effects of adenosine agonists and an antagonist on excitatory transmitter release from the ischemic rabbit hippocampus.
Topics: Adenosine; Animals; Brain Ischemia; Chromatography, High Pressure Liquid; Electroencephalography; Extracellular Space; Glutamic Acid; Hippocampus; Hypothermia, Induced; Injections, Intravenous; Microdialysis; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rabbits; Reperfusion; Theophylline; Xanthines | 2000 |
Alert to physicians: possible interaction of aggrenox and adenosine.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Vasodilator Agents | 2000 |
Opposing effects of adenosine on the survival of glial cells exposed to chemical ischemia.
Topics: Adenosine; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Brain Ischemia; Carrier Proteins; Caspase 3; Caspases; Cell Count; Cell Survival; Cytochrome c Group; Dose-Response Relationship, Drug; Drug Administration Schedule; Glioma; Humans; Neuroglia; Neuroprotective Agents; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2000 |
K(ATP) channel blockers selectively interact with A(1)-adenosine receptor mediated modulation of acetylcholine release in the rat hippocampus.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine; Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Brain Ischemia; Electric Stimulation; Hippocampus; In Vitro Techniques; KATP Channels; Male; Muscarinic Antagonists; Oxotremorine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Receptors, Presynaptic; Receptors, Purinergic P1; Xanthines | 2001 |
Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.
Topics: Adenosine; Animals; Blood Gas Analysis; Blood Pressure; Brain; Brain Ischemia; Carotid Arteries; Cyclic AMP; Energy Metabolism; Interleukin-1; Male; Memory; Microglia; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthines | 2001 |
Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Male; Mice; Neurons; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Stroke | 2001 |
Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia.
Topics: Adenosine; Adenosine Triphosphate; Animals; Brain Ischemia; Corpus Striatum; gamma-Aminobutyric Acid; Male; Membrane Potentials; Neural Inhibition; Organ Culture Techniques; Patch-Clamp Techniques; Potassium Channels; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synaptic Transmission; Triazines; Triazoles; Xanthines | 2001 |
Adenosine A(1) receptor agonism in the immature rat brain and heart.
Topics: Adenosine; Animals; Animals, Newborn; Binding, Competitive; Body Temperature; Brain; Brain Ischemia; Dose-Response Relationship, Drug; Female; Guanosine 5'-O-(3-Thiotriphosphate); Heart; Heart Rate; Hypoxia; Iodine Radioisotopes; Male; Myocardium; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Rectum; Sulfur Radioisotopes; Time Factors; Xanthines | 2001 |
Role of adenosine receptors in neuroprotective effect during global cerebral ischemia.
Topics: Adenosine; Animals; Antihypertensive Agents; Brain Ischemia; Dose-Response Relationship, Drug; Female; Ischemia; Male; Mice; Neurons; Phenethylamines; Receptors, Purinergic P1 | 2001 |
Does adenosine have cerebro-protective effect during cardiopulmonary bypass?
Topics: Adenosine; Brain; Brain Ischemia; Cardiopulmonary Bypass; Humans; Premedication; Prognosis | 2001 |
Role of K(ATP) channels in the induction of ischemic tolerance by the 'adenosine mechanism' in neuronal cultures.
Topics: Adenosine; Animals; Brain Ischemia; Cells, Cultured; Cromakalim; Diglycerides; Glyburide; Neurons; Phenylisopropyladenosine; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats | 2000 |
Influence of inhibition of adenosine uptake on the gamma-aminobutyric acid level of the ischemic rat brain.
Topics: Adenosine; Animals; Biomarkers; Brain; Brain Chemistry; Brain Ischemia; Cerebral Cortex; Dipyridamole; gamma-Aminobutyric Acid; Hippocampus; L-Lactate Dehydrogenase; Male; Rats; Reperfusion Injury; Vasodilator Agents | 2002 |
Adenosine and cyclic AMP in cerebral cortex of rats in hypoxia, status epilepticus and hypercapnia.
Topics: Adenine Nucleotides; Adenosine; Animals; Brain Ischemia; Cerebral Cortex; Cyclic AMP; Hypercapnia; Hypoxia; Male; Partial Pressure; Rats; Seizures | 1978 |
Brain adenosine production in the rat during 60 seconds of ischemia.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Homeostasis; Lactates; Phosphocreatine; Pyruvates; Rats; Time Factors | 1979 |
Changes in brain metabolites during the first 60 seconds of ischemia: adenosine production during hypotension.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Hypotension; Rats | 1978 |
Escape from inhibition of synaptic transmission during in vitro hypoxia and hypoglycemia in the hippocampus.
Topics: Adenosine; Animals; Baclofen; Brain Ischemia; Cell Hypoxia; Electric Stimulation; Electrophysiology; Hippocampus; Hypoglycemia; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Synapses; Synaptic Transmission | 1992 |
Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aspartic Acid; Brain Ischemia; Cerebral Cortex; Glutamates; Glutamic Acid; Male; Neurotransmitter Agents; Purinergic Antagonists; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triazoles; Xanthines | 1992 |
The effect of cyclohexyladenosine on the periischemic increases of hippocampal glutamate and glycine in the rabbit.
Topics: Adenosine; Animals; Brain Ischemia; Glutamates; Glutamic Acid; Glycine; Hippocampus; Rabbits | 1992 |
A neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Ischemia; Deoxyglucose; Hippocampus; In Vitro Techniques; Male; Nervous System Diseases; Phenylisopropyladenosine; Purinergic Antagonists; Rats; Rats, Wistar; Receptors, Purinergic; Theophylline; Vasodilator Agents | 1992 |
Ultrastructural localization of calcium in ischemic hippocampal slices: the influence of adenosine and theophylline.
Topics: Adenosine; Animals; Brain Ischemia; Calcium; Dendrites; Hippocampus; Male; Mitochondria; Organ Culture Techniques; Rats; Rats, Inbred Strains; Theophylline | 1992 |
Sequential changes in muscarinic acetylcholine, adenosine A1 and calcium antagonist binding sites in the gerbil hippocampus following repeated brief ischemia.
Topics: Adenosine; Animals; Autoradiography; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Gerbillinae; Hippocampus; Isradipine; Male; Quinuclidinyl Benzilate; Receptors, Muscarinic; Receptors, Nicotinic; Receptors, Purinergic | 1991 |
Involvement of lipid peroxidation and inhibitory mechanisms on ischemic neuronal damage in gerbil hippocampus: quantitative autoradiographic studies on second messenger and neurotransmitter systems.
Topics: Adenosine; Animals; Autoradiography; Body Temperature; Brain Ischemia; Calcium Channels; Chlorides; Colforsin; Gerbillinae; Hippocampus; Inositol 1,4,5-Trisphosphate; Ion Channels; Lipid Peroxidation; Male; Neurons; Neurotransmitter Agents; Pentobarbital; Phorbol 12,13-Dibutyrate; Quinazolines; Quinuclidinyl Benzilate; Receptors, GABA-A; Second Messenger Systems | 1991 |
[Effects of AMG-1 on energy metabolism and neuronal damage of ischemic brain in mice and rats].
Topics: Adenosine; Agaricales; Animals; Brain; Brain Ischemia; Energy Metabolism; Male; Mice; Nimodipine; Rats; Rats, Inbred Strains | 1991 |
Enhancement of endogenous excitatory amino acids by theophylline does not modify the behavioral and histological consequences of forebrain ischemia.
Topics: Adenosine; Amino Acids; Animals; Brain Ischemia; Dialysis; Male; Prosencephalon; Psychomotor Performance; Rats; Rats, Wistar; Theophylline | 1991 |
The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology.
Topics: Adenosine; Animals; Blood Pressure; Brain Ischemia; Caffeine; Cerebral Cortex; Corpus Striatum; Hippocampus; Histocytochemistry; Magnetic Resonance Imaging; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Purinergic | 1991 |
Influence of hyperglycemia on cerebral adenosine production during ischemia and reperfusion.
Topics: Adenine Nucleotides; Adenosine; Animals; Brain; Brain Ischemia; Hyperglycemia; Hypoxanthine; Hypoxanthines; Inosine; Male; Rats; Rats, Inbred Strains; Reperfusion | 1991 |
Adenosine-induced enhanced recovery of evoked responses after anoxia.
Topics: Adenosine; Animals; Brain Ischemia; Evoked Potentials; Hippocampus; Hypoxia, Brain; In Vitro Techniques; Rats; Synapses; Synaptic Transmission | 1990 |
Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline.
Topics: Adenosine; Animals; Blood Pressure; Brain Ischemia; Drug Interactions; Female; Gerbillinae; Theophylline | 1990 |
Effect of dipyridamole on cerebral extracellular adenosine level in vivo.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Cerebral Cortex; Dialysis; Dipyridamole; Extracellular Space; Swine | 1990 |
Protective effects of cyclohexyladenosine following cerebral ischemia in the gerbil hippocampus.
Topics: Adenosine; Animals; Brain Ischemia; Colforsin; Gerbillinae; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Hippocampus; Random Allocation; Receptors, Purinergic; Time Factors | 1989 |
The adenosine analogue and cerebral protecting agent, AMG-1, has no effect on delayed neuronal death following ischemia.
Topics: Adenosine; Animals; Brain Ischemia; Cell Survival; Gerbillinae; Hippocampus; Male; Mice; Mice, Inbred ICR; Motor Activity; Neurons; Pentobarbital; Sleep | 1989 |
Relative cerebral ischemia in SHR due to hypotensive hemorrhage: cerebral function, blood flow and extracellular levels of lactate and purine catabolites.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Circulation; Extracellular Space; Hypertension; Hypotension; Hypoxanthine; Hypoxanthines; Inosine; Kinetics; Lactates; Lactic Acid; Male; Rats; Rats, Inbred SHR; Xanthine; Xanthines | 1989 |
Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex.
Topics: Adenosine; Animals; Biological Transport, Active; Brain Ischemia; Cerebral Cortex; Dipyridamole; Male; Piperazines; Purines; Rats; Rats, Inbred Strains | 1989 |
Blockade of N-methyl-D-aspartate-sensitive acidic amino acid receptors inhibits ischemia-induced accumulation of purine catabolites in the rat striatum.
Topics: 2-Amino-5-phosphonovalerate; Adenosine; Animals; Brain Ischemia; Corpus Striatum; Hypoxanthine; Hypoxanthines; Inosine; Male; Purines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Valine; Xanthine; Xanthines | 1986 |
Cyclic AMP concentrations in rat neocortex and hippocampus during and following incomplete ischemia: effects of central noradrenergic neurons, prostaglandins, and adenosine.
Topics: Adenosine; Animals; Brain Ischemia; Cerebral Cortex; Cyclic AMP; Energy Metabolism; Fatty Acids, Nonesterified; Glycolysis; Hippocampus; Indomethacin; Locus Coeruleus; Male; Norepinephrine; Prostaglandins; Rats; Theophylline | 1985 |
Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus.
Topics: Adenosine; Animals; Brain Ischemia; Cell Survival; Gerbillinae; Hippocampus; Injections, Intraventricular; Male; Neurons | 1988 |
An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus.
Topics: 2-Chloroadenosine; Adenosine; Animals; Brain Ischemia; Cell Survival; Hippocampus; Male; Rats; Rats, Inbred Strains | 1987 |
Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole.
Topics: Adenosine; Adenosine Diphosphate; Adult; Aged; Brain Ischemia; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation | 1987 |
Quantitative autoradiographic analysis of muscarinic cholinergic and adenosine A1 binding sites after transient forebrain ischemia in the gerbil.
Topics: Adenosine; Animals; Autoradiography; Brain Ischemia; Diencephalon; Gerbillinae; Quinuclidinyl Benzilate; Receptors, Muscarinic; Receptors, Purinergic; Telencephalon | 1987 |
Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia.
Topics: Adenosine; Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Dialysis; Extracellular Space; Hypoxanthine; Hypoxanthines; Hypoxia, Brain; Inosine; Male; Potassium; Rats; Rats, Inbred Strains | 1986 |
Effect of gamma-hydroxybutyrate on the reactivity of pial arteries before and after ischemia.
Topics: Adenosine; Animals; Arteries; Brain Ischemia; Cats; Cerebrovascular Circulation; Embolism, Air; Female; Hydroxybutyrates; Intracranial Embolism and Thrombosis; Male; Microinjections; Pia Mater; Sodium Oxybate | 1986 |
Effect of theophylline on ischemically induced hippocampal damage in Mongolian gerbils: a behavioral and histopathological study.
Topics: Adenosine; Animals; Behavior, Animal; Brain Ischemia; Cerebrovascular Circulation; Gerbillinae; Hippocampus; Male; Necrosis; Receptors, Purinergic; Theophylline | 1987 |
[Formation of adenine nucleotides from adenosine in the brain of rats during oxygen insufficiency].
Topics: Adenine Nucleotides; Adenosine; Animals; Brain; Brain Ischemia; Hypoxia, Brain; In Vitro Techniques; Rats; Rats, Inbred Strains | 1985 |